Clinical Trials Directory

Trials / Completed

CompletedNCT02562469

ACTIVATE: A Computerized Training Program for Children With ADHD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
New York University · Academic / Other
Sex
All
Age
7 Years – 11 Years
Healthy volunteers
Not accepted

Summary

A preliminary clinical trial of ACTIVATE will be conducted in a sample of children with ADHD. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking).

Detailed description

In an open clinical trial, ACTIVATE, a computer-based neurocognitive intervention will be evaluated to determine its effectiveness in improving symptoms of attention-deficit/hyperactivity disorder (ADHD) and related impairments. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking). Youth between the ages of 7-11 will be recruited and assessed for ADHD and assigned to the ACTIVATE intervention. Assessment of outcomes will occur before, weekly during treatment, and immediately post-treatment.

Conditions

Interventions

TypeNameDescription
OTHERACTIVATEA home-based computerized brain training intervention for youth.

Timeline

Start date
2015-09-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2015-09-29
Last updated
2022-11-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02562469. Inclusion in this directory is not an endorsement.